Giving the anti-clotting drug rivaroxaban to patients for 12 weeks instead of the usual six after a blood clot in the lower leg reduces the risk of further clots developing up to two years after ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window AMSTERDAM -- A ...

What is a blood clot? Blood clots normally form after an injury to protect your body from losing too much blood, but they can also develop in an artery or vein even if there is no obvious injury.

If the choice is made to anticoagulate patients with symptomatic isolated distal deep vein thrombosis (DVT), outcomes will be improved with 12 versus 6 weeks of treatment, the randomized, ...

Please provide your email address to receive an email when new articles are posted on . Adults with isolated distal deep vein thrombosis experience fewer short- and long-term adverse outcomes compared ...

Please provide your email address to receive an email when new articles are posted on . Longer vs. shorter-duration anticoagulation reduces thrombotic event risk for patients with cancer and isolated ...

Age-adjusted D-dimer cutoffs can safely rule out deep vein thrombosis (DVT) in many suspected cases, according to the ...

Our legs do much more than carry our entire body weight; they can also serve as a window to our health. Many health ...

Rivaroxaban is an anticoagulant drug. It’s given to people at a high risk of getting dangerous blood clots to help their blood clot (thicken) more slowly. Anticoagulation is known to prevent further ...